PharmaShots | Incisive News in 3 Shots

Subscribe Now

Gastrointestinal Stromal Tumor

Deciphera Pharmaceuticals' Qinlock (ripretinib) Receives the US FDA's Approval to Treat 4L Gastrointestinal Stromal Tumor

Deciphera Pharmaceuticals' Qinlock (ripretinib) Receives the US FDA's Approval to Treat 4L Gastrointestinal Stromal Tumor

May 15, 2020

Blueprint Medicines' Ayvakit (avapritinib) Receives FDA's Approval to Treat Patients with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor

Blueprint Medicines' Ayvakit (avapritinib) Receives FDA's Approval to Treat Patients with Unresectable or Metastatic PDGFRA Exon 1...

January 9, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us